Grifols SA
- Biotech or pharma, therapeutic R&D
- Investor (buy-side or sell-side research)
Grifols is a healthcare company committed to improving people’s health. Our more than 24,000 employees in over 30 countries develop, produce, and market plasma-derived medicines as well as innovative biotech and diagnostic solutions.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}